MedTrace Logo

Early Geriatric Follow-up in Older Acute Medical Patients

NCT02664948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2362

Last updated 2019-05-01

No results posted yet for this study

Summary

The study is a quasi-randomized controlled trial conducted in a Danish University Hospital including older patients admitted to Emergency Department (ED). 'Early geriatric follow-up' is a multidisciplinary geriatric service provided to older patients who are discharged to their home. They receive hospital-visits by a multidisciplinary team no later than 24 hours after discharge (except on sundays). The team is consisting of a physician and a nurse both with geriatric expertise. The physician is responsible for the clinical patient care. The team is available seven days per week/12 hours per day and 24 hour on-call. In the patient's home, the team has the possibility to perform diagnosing and treatment by assessments, medication review, blood tests, subcutaneous fluid therapy, blood transfusions, intravenous antibiotics, rehabilitation and social arrangements. A discharge hand-over supports the caregivers and the GP.

Conditions

  • Geriatric Disorder

Interventions

PROCEDURE

Early geriatric follow-up after discharge

Multidisciplinary assessement and intervention by physician, nurse and physiotherapist

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Else Marie Damsgaard, Professor · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02664948 on ClinicalTrials.gov